HEADINGLEY PROJECTS LIMITED

Company number 13261858 ·

Active - Proposal to Strike off

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

HEADINGLEY PROJECTS LIMITED - Analysis Report

Company Number: 13261858

Analysis Date: 2025-07-20 18:15 UTC

Financial Health Assessment Report: HEADINGLEY PROJECTS LIMITED


1. Financial Health Score: D

Explanation:
The company currently exhibits significant financial distress symptoms, primarily due to negative net asset value and absence of current assets, indicating liquidity challenges and potential solvency risks. The financial figures suggest the business is under stress and requires urgent remedial measures.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Fixed Assets 0 Complete loss or disposal of long-term assets compared to prior year (£1,097,290) signals asset liquidation or impairment.
Current Assets 0 No short-term liquid assets available to cover liabilities — a critical red flag for cash flow health.
Current Liabilities 116,374 Short-term debts remain significant and are not matched by current assets, indicating working capital deficiency.
Net Current Assets (Working Capital) -116,374 Negative working capital ("symptom of distress") suggests difficulty in meeting short-term obligations.
Net Assets -116,374 Negative equity indicates the company owes more than it owns, a key indicator of insolvency risk.
Share Capital 75.00 Minimal share capital; reliance on external funding or liabilities to finance operations.
Employees 0 No employees, which may reflect minimal operational activity or cost-cutting measures.

3. Diagnosis

The financial "vital signs" reveal alarming symptoms: total disappearance of fixed and current assets, coupled with significant current liabilities, has driven the company into negative net assets territory. This situation is akin to a patient having lost vital organ functions (assets) but still carrying heavy "debts" (liabilities) that it cannot service.

Comparing 2023 to 2024, the company’s financial health has deteriorated sharply:

  • The company had substantial fixed and current assets in 2023 but these were entirely depleted by 2024.
  • The current liabilities remain, but with no assets to cover them, the company is effectively insolvent on a balance sheet basis.
  • The presence of only one director currently, and no employees, combined with asset depletion, may indicate either a winding down of business activity or severe operational difficulties.
  • The company is classified as a micro-entity, limiting the scale of operations and financial buffer.
  • The ownership and control by Pharmacy Plus Health Limited and a director with 25-50% shareholding suggest some external influence, but the financial structure indicates distress.

Overall, the diagnosis points to a company in serious financial difficulty, potentially facing insolvency unless remedial actions are taken immediately.


4. Recommendations

To restore financial wellness and stabilize the business, the company should consider the following steps urgently:

  1. Conduct a Cash Flow Analysis:
    Assess current and projected cash inflows and outflows to understand liquidity needs and timing for debt servicing.

  2. Engage with Creditors:
    Negotiate payment terms or restructuring of liabilities to alleviate short-term cash pressure and prevent enforcement actions.

  3. Asset Review:
    If any assets remain off-balance sheet or tangible/intangible assets can be monetized, pursue sale or refinancing options to raise funds.

  4. Capital Injection:
    Consider seeking new equity investment or shareholder loans to improve net asset position and fund operations.

  5. Operational Review:
    Evaluate business activities to identify cost-saving opportunities, potential revenue streams, or strategic pivots to improve financial viability.

  6. Professional Advice:
    Consult insolvency practitioners or financial advisors to explore formal restructuring options, including administration or voluntary arrangements, if necessary.

  7. Compliance and Reporting:
    Ensure timely filing of accounts and confirmation statements to avoid penalties and maintain stakeholder confidence.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.